Skip to search formSkip to main contentSkip to account menu

Complement C3 Nephritic Factor

Known as: Complement C3 Nephritic Factor [Chemical/Ingredient], C3 Nephritic Factor, C 3 Nephritic Factor 
An IgG autoantibody against the ALTERNATIVE PATHWAY C3 CONVERTASE, found in serum of patients with MESANGIOCAPILLARY GLOMERULONEPHRITIS. The binding… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
BACKGROUND AND OBJECTIVES The principle defect in dense deposit disease and C3 glomerulonephritis is hyperactivity of the… 
Highly Cited
2010
Highly Cited
2010
Highly Cited
2008
Highly Cited
2008
We describe the clinical features of 28 patients with juvenile dermatomyositis (JDM) and 1 patient with adult-onset… 
Highly Cited
2006
Highly Cited
2006
Introduction: Abnormal control of the complement alternative pathway (CAP) (factor H, factor I and membrane cofactor protein (MCP… 
Highly Cited
2006
Highly Cited
2006
Increased monocyte/macrophage (Mφ) apoptosis occurs in patients with systemic lupus erythematosus (SLE) and is mediated, at least… 
Highly Cited
2001
Highly Cited
2001
Fifty children with idiopathic membranoproliferative glomerulonephritis (MPGN), aged 2–14 years at apparent onset, were monitored… 
Review
1997
Review
1997
  • D. Williams
  • Pediatric nephrology (Berlin, West)
  • 1997
  • Corpus ID: 20067881
Abstract. The association of a C3 splitting activity, known as C3 nephritic factor (C3NeF), with mesangiocapillary… 
Highly Cited
1994
Highly Cited
1994
We have observed that decreased plasma levels of C3 in the serum of three children with poststreptococcal acute… 
Highly Cited
1977
Highly Cited
1977
Complement C3 nephritic factor (NeF) produces alternative pathway-meciated C3 cleavage by binding to and stabilizing the… 
Highly Cited
1976
Highly Cited
1976
C3 nephritic factor (C3NeF) defined by the capacity of nephritic serum and its fractions to initiate loss of the B antigen of C3…